Tool-like receptors in Systemic Autoimmune Disease
02/11/2010 - 06/30/2014 (Subcontract PI)University of Massachusetts, Worcester NIH NIAMS5P01AR050256-11
Role of Toll-like Receptors in Dendritic Cell Activation by Chromatin-Containing Immune Complexes
08/01/2002 - 01/31/2007 (PI)The Lupus Research Institute Inc
Toll-like Receptors in the Pathogenesis of SLE and Immunologically-Mediated Renal Disease
04/01/2002 - 12/31/2006 (Co-PI)Coley Pharmaceutical Group
Lupus Nephritis Molecular Studies Using Transcriptomics
06/02/2022 - 06/02/2026 (PI)Visterra, Inc.
Evaluation of gene expression at the single cell level in kidney biopsies and urine from patients with glomerulonephritis
07/01/2020 - 06/30/2024 (PI)Chugai Pharmaceutical Co., Ltd
The Role of Interferon Regulatory Factor 5 in the Pathogenesis of SLE
09/01/2019 - 08/31/2023 (PI)National Institute of Allergy and Infectious Diseases/NIH/DHHS5R01AI130199-02
Dr. Rifkin _ Sanofi
04/20/2020 - 04/19/2023 (PI)Sanofi US Services Inc.
Immunomodulator Identification in Systemic Lupus Erythematosus
12/02/2015 - 06/02/2021 (PI)Merck
The role of innate immune system mediators and pathways in SLE pathogenesis
12/21/2015 - 12/20/2018 (PI)Merck
Evaluation of antibodies for the treatment of autoimmune diseases
03/01/2016 - 04/30/2018 (PI)Chugai Pharmaceutical, Co., Ltd.
Evaluating impact of Biogen IRAK 4 inhibitors on metabolism and generation of human plasmacytoid den
09/23/2013 - 09/30/2016 (PI)Biogen, Inc
SLE-immune complex-mediated inflammatory cell activation: regulation by IRF5 and new effector discov
11/01/2012 - 08/31/2015 (PI)Kyowa Hakko Kirin Co.
IRAK4 Kinase and Autoimmune Disease
10/01/2011 - 09/30/2013 (PI)Biogen, Inc
Showing 10 of 16 results.
Show All Results